BioSpace News Archive

Forecast to 2030,’ thoroughly examines the Interstitial Cystitis industry to provide essential data & information for the targeted readers.

Forecast to 2030,’ thoroughly examines the Merkel Cell Carcinoma industry to provide essential data & information for the targeted readers.

Forecast to 2030,’ thoroughly examines the Myelofibrosis industry to provide essential data & information for the targeted readers.

Soligenix, Inc. (NASDAQ: SNGX) (Soligenix or the Company), announced today that the results of its successful Phase 3 FLASH (Fluorescent Light Activated Synthetic Hypericin) study evaluating HyBryte™ (synthetic hypericin) for the treatment of cutaneous T-cell lymphoma (CTCL) has been published in the Journal of the American Medical Association (JAMA) Dermatology.

Neogen Corporation held a ceremonial groundbreaking in anticipation of approvals on a $70 million expansion of their Lansing, Michigan, food safety facility.

Brainomix, the AI-powered medtech solutions company, today announces that it has appointed Melissa Strange as Chief Financial Officer (CFO) and Jérôme Galbrun as Chief Revenue Officer (CRO).

Nexus Spine, a developer of biomechanically-advanced solutions for spinal pathologies, today announced the beta launch of its Stable-C™ cervical interbody fusion implants featuring integrated anchoring blades.

The cardiovascular proximal anastomosis devices market is slated to clock a favorable CAGR of ~6% during the assessment period.

The cell line authentication and characterization tests market is expected to expand at a CAGR of 8.4% from 2022 to 2030.

SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release second quarter financial results after the close of trading on Tuesday, August 2, 2022.